The following table summarizes the computation of basic and diluted net income per share of our common stock for the three and six months ended June 30, 2026 and 2025 (in thousands, except share and per share data):


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Numerator:
Net income attributable to common stockholders, basic and diluted	$	6,073	$	8,338	$	7,203	$	10,443

Denominator:
Weighted average common shares outstanding, basic	67,024,154		64,441,000		66,601,615		64,140,087
Weighted average effect of dilutive shares:
Dilutive effect of equity incentive plans	895,807		255,992		813,525		322,231

Weighted average common shares outstanding, diluted	67,919,961		64,696,992		67,415,140		64,462,318

Net income per share attributable to common stockholders, basic	$	0.09	$	0.13	$	0.11	$	0.16
Net income per share attributable to common stockholders, diluted	$	0.09	$	0.13	$	0.11	$	0.16

We intend to settle any conversion of our 2027 Notes and 2029 Notes in cash, shares, or a combination thereof. The dilutive impact of the Notes for our calculation of diluted net income per share is considered using the if-converted method. For the three and six months ended June 30, 2026 and 2025, the shares underlying the Notes were not considered in the calculation of diluted net income per share as the effect would have been anti-dilutive.

In connection with the issuance of the 2027 Notes and the 2029 Notes, we entered into the 2027 Capped Calls and 2029 Capped Calls, which were not included for the purpose of calculating the number of diluted shares outstanding, as their effect would have been anti-dilutive.

As of June 30, 2026 and 2025, the 2027 Notes and the 2029 Notes were not convertible at the option of the holder. We had not received any conversion notices through the issuance date of our consolidated financial statements. For disclosure purposes, we have calculated the potentially dilutive effect of the conversion spread, which is included in the table below. The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding for the respective periods below because they would have been anti-dilutive:


	Three Months Ended June 30,		Six Months Ended June 30,
	2026	2025	2026	2025
Options to purchase common stock	219,941	—	221,401	—

Common shares issued in conjunction with acquisitions	610,821	342,962	1,555,116	338,527
Shares to be issued under ESPP	307,992	129,195	307,992	129,195
Convertible senior notes	10,429,891	10,429,891	10,429,891	10,429,891
Total	11,568,645	10,902,048	12,514,400	10,897,613